<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title></title>
    <link>https://stablemarkets.netlify.app/</link>
      <atom:link href="https://stablemarkets.netlify.app/index.xml" rel="self" type="application/rss+xml" />
    <description></description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Thu, 27 Mar 2025 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://stablemarkets.netlify.app/media/icon_hu56437e0029043a6980b2632a303bfe7c_22443_512x512_fill_lanczos_center_3.png</url>
      <title></title>
      <link>https://stablemarkets.netlify.app/</link>
    </image>
    
    <item>
      <title>Python basics</title>
      <link>https://stablemarkets.netlify.app/courses/example/python/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/courses/example/python/</guid>
      <description>&lt;p&gt;Build a foundation in Python.&lt;/p&gt;
&lt;p&gt;
  &lt;i class=&#34;fas fa-clock  pr-1 fa-fw&#34;&gt;&lt;/i&gt; 1-2 hours per week, for 8 weeks&lt;/p&gt;
&lt;h2 id=&#34;learn&#34;&gt;Learn&lt;/h2&gt;

&lt;div style=&#34;position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;&#34;&gt;
  &lt;iframe src=&#34;https://www.youtube.com/embed/rfscVS0vtbw&#34; style=&#34;position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;&#34; allowfullscreen title=&#34;YouTube Video&#34;&gt;&lt;/iframe&gt;
&lt;/div&gt;

&lt;h2 id=&#34;quiz&#34;&gt;Quiz&lt;/h2&gt;
&lt;details class=&#34;spoiler &#34;  id=&#34;spoiler-2&#34;&gt;
  &lt;summary&gt;What is the difference between lists and tuples?&lt;/summary&gt;
  &lt;p&gt;&lt;p&gt;Lists&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Lists are mutable - they can be changed&lt;/li&gt;
&lt;li&gt;Slower than tuples&lt;/li&gt;
&lt;li&gt;Syntax: &lt;code&gt;a_list = [1, 2.0, &#39;Hello world&#39;]&lt;/code&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Tuples&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Tuples are immutable - they can&amp;rsquo;t be changed&lt;/li&gt;
&lt;li&gt;Tuples are faster than lists&lt;/li&gt;
&lt;li&gt;Syntax: &lt;code&gt;a_tuple = (1, 2.0, &#39;Hello world&#39;)&lt;/code&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/p&gt;
&lt;/details&gt;
&lt;details class=&#34;spoiler &#34;  id=&#34;spoiler-3&#34;&gt;
  &lt;summary&gt;Is Python case-sensitive?&lt;/summary&gt;
  &lt;p&gt;Yes&lt;/p&gt;
&lt;/details&gt;</description>
    </item>
    
    <item>
      <title>Visualization</title>
      <link>https://stablemarkets.netlify.app/courses/example/visualization/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/courses/example/visualization/</guid>
      <description>&lt;p&gt;Learn how to visualize data with Plotly.&lt;/p&gt;
&lt;p&gt;
  &lt;i class=&#34;fas fa-clock  pr-1 fa-fw&#34;&gt;&lt;/i&gt; 1-2 hours per week, for 8 weeks&lt;/p&gt;
&lt;h2 id=&#34;learn&#34;&gt;Learn&lt;/h2&gt;

&lt;div style=&#34;position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden;&#34;&gt;
  &lt;iframe src=&#34;https://www.youtube.com/embed/hSPmj7mK6ng&#34; style=&#34;position: absolute; top: 0; left: 0; width: 100%; height: 100%; border:0;&#34; allowfullscreen title=&#34;YouTube Video&#34;&gt;&lt;/iframe&gt;
&lt;/div&gt;

&lt;h2 id=&#34;quiz&#34;&gt;Quiz&lt;/h2&gt;
&lt;details class=&#34;spoiler &#34;  id=&#34;spoiler-2&#34;&gt;
  &lt;summary&gt;When is a heatmap useful?&lt;/summary&gt;
  &lt;p&gt;Lorem ipsum dolor sit amet, consectetur adipiscing elit.&lt;/p&gt;
&lt;/details&gt;
&lt;details class=&#34;spoiler &#34;  id=&#34;spoiler-3&#34;&gt;
  &lt;summary&gt;Write Plotly code to render a bar chart&lt;/summary&gt;
  &lt;p&gt;&lt;pre&gt;&lt;code class=&#34;language-python&#34;&gt;import plotly.express as px
data_canada = px.data.gapminder().query(&amp;quot;country == &#39;Canada&#39;&amp;quot;)
fig = px.bar(data_canada, x=&#39;year&#39;, y=&#39;pop&#39;)
fig.show()
&lt;/code&gt;&lt;/pre&gt;
&lt;/p&gt;
&lt;/details&gt;</description>
    </item>
    
    <item>
      <title>Statistics</title>
      <link>https://stablemarkets.netlify.app/courses/example/stats/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/courses/example/stats/</guid>
      <description>&lt;p&gt;Introduction to statistics for data science.&lt;/p&gt;
&lt;p&gt;
  &lt;i class=&#34;fas fa-clock  pr-1 fa-fw&#34;&gt;&lt;/i&gt; 1-2 hours per week, for 8 weeks&lt;/p&gt;
&lt;h2 id=&#34;learn&#34;&gt;Learn&lt;/h2&gt;
&lt;p&gt;The general form of the &lt;strong&gt;normal&lt;/strong&gt; probability density function is:&lt;/p&gt;
&lt;p&gt;$$
f(x) = \frac{1}{\sigma \sqrt{2\pi} } e^{-\frac{1}{2}\left(\frac{x-\mu}{\sigma}\right)^2}
$$&lt;/p&gt;
&lt;div class=&#34;alert alert-note&#34;&gt;
  &lt;div&gt;
    The parameter $\mu$ is the mean or expectation of the distribution.
$\sigma$ is its standard deviation.
The variance of the distribution is $\sigma^{2}$.
  &lt;/div&gt;
&lt;/div&gt;

&lt;h2 id=&#34;quiz&#34;&gt;Quiz&lt;/h2&gt;
&lt;details class=&#34;spoiler &#34;  id=&#34;spoiler-2&#34;&gt;
  &lt;summary&gt;What is the parameter $\mu$?&lt;/summary&gt;
  &lt;p&gt;The parameter $\mu$ is the mean or expectation of the distribution.&lt;/p&gt;
&lt;/details&gt;</description>
    </item>
    
    <item>
      <title>causalBETA</title>
      <link>https://stablemarkets.netlify.app/project/causalbeta/</link>
      <pubDate>Thu, 27 Mar 2025 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/project/causalbeta/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Causal Inference with Recurrent Event Outcomes</title>
      <link>https://stablemarkets.netlify.app/talk/bayesian-causal-inference-with-recurrent-event-outcomes/</link>
      <pubDate>Mon, 24 Mar 2025 15:05:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/bayesian-causal-inference-with-recurrent-event-outcomes/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Bayesian Framework for Causal Analysis of Recurrent Events with Timing Misalignment</title>
      <link>https://stablemarkets.netlify.app/publication/bayesrecurrent/</link>
      <pubDate>Fri, 15 Nov 2024 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/bayesrecurrent/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Counterfactual Prediction and Optimization with Incomplete Information</title>
      <link>https://stablemarkets.netlify.app/talk/bayesian-counterfactual-prediction-and-optimization-with-incomplete-information/</link>
      <pubDate>Tue, 02 Jul 2024 15:05:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/bayesian-counterfactual-prediction-and-optimization-with-incomplete-information/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Semiparametric Model for Sequential Treatment Decisions with Informative Timing</title>
      <link>https://stablemarkets.netlify.app/publication/bayesdtraml/</link>
      <pubDate>Fri, 05 Jan 2024 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/bayesdtraml/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Semiparametric Inference for Dynamic Treatment Strategies with Informative Timing</title>
      <link>https://stablemarkets.netlify.app/talk/bayesian-semiparametric-inference-for-dynamic-treatment-strategies-with-informative-timing/</link>
      <pubDate>Tue, 01 Aug 2023 15:05:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/bayesian-semiparametric-inference-for-dynamic-treatment-strategies-with-informative-timing/</guid>
      <description></description>
    </item>
    
    <item>
      <title>For prospective Brown advisees</title>
      <link>https://stablemarkets.netlify.app/post/post7/advising/</link>
      <pubDate>Sat, 01 Jul 2023 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/post/post7/advising/</guid>
      <description>


&lt;div id=&#34;advising&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Advising&lt;/h2&gt;
&lt;p&gt;Working with graduate students is a very fulfilling part of my job. Philosophically, I am not a very hierarchical person and I see students as fellow researchers. We work as part of a team to solve a common problem. The learning/mentoring happens on the journey towards finding these solutions and I sometimes find myself learning from students as well. I also like to foster independence, typically starting off with a lot of guidance and direction and then tapering incrementally over time.&lt;/p&gt;
&lt;p&gt;I typically work with Brown University graduate students in the capacity of a thesis or dissertation adviser for the &lt;a href=&#34;https://biostatistics.sph.brown.edu/academics&#34;&gt;ScM and PhD programs in Biostatistics&lt;/a&gt;. How many students I take on depends on availability of funding and data projects. I generally do not take on more than two new students per year.&lt;/p&gt;
&lt;p&gt;If you think you may like to work with me on a thesis, I first suggest you read the “Assessing Interest’’ and the  ``Finding a Project” sections below and go through some of the papers listed. If you feel like you are enjoying what you are reading and find it stimulating, feel free to email me to set up a meeting to discuss your interests and goals. I also summarize some placement outcomes for past advisees at the end of this post..&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&#34;assessing-interest&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Assessing Interest&lt;/h2&gt;
&lt;p&gt;My current research interests are in causal inference for sequential (aka time-varying) treatment settings. Lately, most of the problems that have come my way deal with survival or, more generally, event-time outcomes. When it comes to methods for estimation or inference on causal effects of treatments on these survival outcomes, I tend to work within the Bayesian paradigm. Thus, working with me typically requires working at the intersection of 1) causal inference, 2) survival analysis, and 3) Bayesian methods. Projects need not involve these - for instance, I also like working on causal inference using frequentist methods when applicable or on other types of outcomes aside from survival. But generally, at least causal inference and Bayesian methods are a common thread.&lt;/p&gt;
&lt;p&gt;In terms of computing, knowledge in a statistical programming language like R is critical. For Bayesian inference, knowledge of probabilistic programming language such as Stan is also critical. Some more elaborate Bayesian models cannot be fit in Stan and the Markov Chain Monte Carlo (MCMC) methods must be coded from scratch.&lt;/p&gt;
&lt;p&gt;Below, I have resources for each of these topics to help you learn and gauge your own interest in these topics.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Causal Inference&lt;/strong&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://www.hsph.harvard.edu/miguel-hernan/wp-content/uploads/sites/1268/2024/04/hernanrobins_WhatIf_26apr24.pdf&#34;&gt;What If&lt;/a&gt;
&lt;ul&gt;
&lt;li&gt;Chapters 1-3: single treatment setting.&lt;/li&gt;
&lt;li&gt;Chapters 11-13: Marginal structural models: estimation via IPTW estimation and g-formula.&lt;/li&gt;
&lt;li&gt;Chapters 19-21: time-varying treatments.&lt;/li&gt;
&lt;/ul&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Bayesian Inference&lt;/strong&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;http://www.stat.columbia.edu/~gelman/book/BDA3.pdf&#34;&gt;Bayesian Data Analysis&lt;/a&gt;
&lt;ul&gt;
&lt;li&gt;Chapters 1, 2, 14, and 11&lt;/li&gt;
&lt;/ul&gt;&lt;/li&gt;
&lt;li&gt;Primer on MCMC &lt;a href=&#34;https://www.cs.ubc.ca/~arnaud/andrieu_defreitas_doucet_jordan_intromontecarlomachinelearning.pdf&#34;&gt;here&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://link.springer.com/book/10.1007/978-3-319-18968-0&#34;&gt;Bayesian nonparametric data analysis&lt;/a&gt; - access free via Brown University library.&lt;/li&gt;
&lt;li&gt;A good rule of thumb is that you should be able to derive the posterior (up to a proportionality constant) for a logistic regression coefficient vector under, say, a multivariate Gaussian prior. You should also be able code a Metropolis-Hastings sampling for obtaining draws from that posterior. It’s also a good way of gauging whether you like computation.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Bayesian causal inference&lt;/strong&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://onlinelibrary.wiley.com/doi/epdf/10.1002/sim.8761&#34;&gt;Practical Introduction to Bayesian estimation of causal effects&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.routledge.com/Bayesian-Nonparametrics-for-Causal-Inference-and-Missing-Data/Daniels-Linero-Roy/p/book/9780367341008?srsltid=AfmBOooQdwAQGPuRQ3aKSf_rdO_es0NP_ijM3bR0Q1l4JPQrcrnF7_8U&#34;&gt;Bayesian Nonparametrics for Causal Inference and Missing Data&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://projecteuclid.org/journals/statistical-science/volume-33/issue-2/Causal-Inference-A-Missing-Data-Perspective/10.1214/18-STS645.full&#34;&gt;Causal Inference: A Missing Data Perspective&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://royalsocietypublishing.org/doi/10.1098/rsta.2022.0153&#34;&gt;Bayesian causal inference: a critical review&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Survival outcomes&lt;/strong&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Bayesian causal inference with survival outcomes see &lt;a href=&#34;https://arxiv.org/abs/2310.12358&#34;&gt;here&lt;/a&gt;:&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://link.springer.com/book/10.1007/978-1-4757-3447-8&#34;&gt;Bayesian Survival Analysis&lt;/a&gt; by Ibrahim. Available via Brown University library. See Chapters 1,2, and 3.&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
&lt;div id=&#34;finding-a-project&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Finding a Project&lt;/h2&gt;
&lt;p&gt;Though it can happen many ways, typically a a thesis advising position has arisen in these ways for me:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;p&gt;A student approaches me and has read some of the literature in the “Assessing Interest” section in detail and concluded they are interested in working in this area. If I have an appropriate project that can be completed within 1-1.5 years ready, I will offer this project as a thesis project for the student. If I do not have a project ready, I will keep the student in mind for when an appropriate project does come my way.&lt;/p&gt;&lt;/li&gt;
&lt;li&gt;&lt;p&gt;A student approaches me usually after having done a previous RA-ship working with data. They are very interested in, say, a causal (or Bayesian) extension of the analysis and would like me to supervise. This is an example of a student coming to me with a project, which does sometimes happen and which I like because it can expose me to new and interesting problems.&lt;/p&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;My work is very application-driven. I’m quite bad at (and generally do not enjoy) making up methodological problems to solve and. Instead, I generate research ideas by working with clinical and applied collaborators in, say, the Department of Epidemiology or the medical school on concrete data analysis. Over the course of working on these projects, I often notice complexities for which I find existing methods to be unsatisfactory or have shortcomings. This then motivates new methodological research to overcome these shortcomings. Thesis work often arises from these concrete data analyses projects with collaborators - the arrival of these projects and their appropriateness for thesis work is stochastic in nature. I may not have an appropriate project lined up when you approach me. If I do not, you should keep searching for other projects and not assume one will pop up in the meantime.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&#34;current-students-and-past-placements&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;Current Students and Past Placements&lt;/h2&gt;
&lt;p&gt;Below are previous students, degree completed, year of completion, and first industry or academic placement after graduation. Brown archives completed ScM theses &lt;a href=&#34;https://repository.library.brown.edu/studio/search/?q=biostatistics&amp;amp;selected_facets=ir_collection_name%3ABiostatistics&#34;&gt;here&lt;/a&gt;. I recommend prospective advisees read through some of the theses from my former students to get a sense of the type of projects they can work on.&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Current Students
&lt;ul&gt;
&lt;li&gt;Esteban Fernandes-Morales, PhD 2026.&lt;/li&gt;
&lt;li&gt;Valentin Kirilenko, ScM 2027.&lt;/li&gt;
&lt;li&gt;Yuzhou Peng, ScM 2027.&lt;/li&gt;
&lt;li&gt;Zizhao Xie, ScM 2027.&lt;/li&gt;
&lt;/ul&gt;&lt;/li&gt;
&lt;li&gt;Previous Students
&lt;ul&gt;
&lt;li&gt;Zhaoxiang Ding, ScM 2025 - Statistician @ Eli Lilly.&lt;/li&gt;
&lt;li&gt;Zihan Zhou, ScM 2024 - Biostatistics PhD @ Pennsylvania State University.&lt;/li&gt;
&lt;li&gt;Tova Ibbotson, ScM 2024 - Senior Statistician @ GSK.&lt;/li&gt;
&lt;li&gt;Nancy Liu, ScM 2023 - Biostatistician @ Rutgers University.&lt;/li&gt;
&lt;li&gt;Anthony Girard, ScM 2023 - Statistical Analyst @ Leonard Davis Institute, University of Pennsylvania.&lt;/li&gt;
&lt;/ul&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Hierarchical Bayesian Bootstrap for Heterogeneous Treatment Effect Estimation</title>
      <link>https://stablemarkets.netlify.app/publication/hbb/</link>
      <pubDate>Thu, 22 Dec 2022 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/hbb/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Sequential Decision-Making with Informative Timing</title>
      <link>https://stablemarkets.netlify.app/post/post6/bayeseq_aml/</link>
      <pubDate>Sat, 03 Dec 2022 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/post/post6/bayeseq_aml/</guid>
      <description>
&lt;script src=&#34;https://stablemarkets.netlify.app/rmarkdown-libs/header-attrs/header-attrs.js&#34;&gt;&lt;/script&gt;


&lt;p&gt;This post is a brief summary of highlights from our &lt;a href=&#34;https://arxiv.org/abs/2211.16393&#34;&gt;recent working paper&lt;/a&gt; titled “Bayesian Semiparametric Model for Sequential Treatment Decisions with Informative Timing.” It’s part of a series of projects on developing robust Bayesian nonparametric models for sequential decision making in a variety of complex settings. In this case, we deal with a situation in which the decisions are informatively timed - with a motivating application in chemotherapy treatments for pediatric acute myeloid leukemia (AML).&lt;/p&gt;
&lt;p&gt;This is partially funded by a &lt;a href=&#34;https://www.pcori.org/research-results/2022/statistical-methods-optimizing-dynamic-patient-level-treatment-and-monitoring-strategies&#34;&gt;PCORI grant&lt;/a&gt; grant awarded earlier this year (2022).&lt;/p&gt;
&lt;div id=&#34;setting-and-problem&#34; class=&#34;section level1&#34;&gt;
&lt;h1&gt;Setting and Problem&lt;/h1&gt;
&lt;p&gt;Chemotherapy treatment in AML is not “one and done” but involves making a sequence of treatment decisions over time, with each subsequent treatment decision depending on how the patient has responded to previous treatments and the evolution of their disease process. There are many chemo agents. This work focuses on understanding the effect of anthracyclines (ACT) in particular on survival. ACT is known to be effective in certain cases, but it can also lead to cardiotoxicity and subsequent early death.&lt;/p&gt;
&lt;p&gt;This presents clinicians with a risk-reward tradeoff - trting too aggressively or too conservatively with ACT may reduce survival. To help inform decisions, an echocardiogram is done to help decide if the heart is healthy enough to tolerate ACT. Clinicians follow various rules of thumb in practice. For instance: withholding ACT if a patient’s current ejection fraction (measured via echocardiogram) falls below some absolute threshold (eg 50%) or if it declines more than some relative (e.g. declines more than 20% from time of enrollment). Briefly, ejection fraction (EF) is the proportion of blood that is pumped out of the heart’s left ventricle during a beat. In healthy individuals, this is fairly high (from 50-75%) but can be lower among patients with cardiotoxicity. These treatment rules are “dynamic” in that ACT is decided based on evolving ejection fraction. This is in contrast to static rules such as “always treat with ACT”, “never treat with ACT” or “alternate ACT” - regardless of EF. The goal is to develop a strategy for estimating survival rates under various hypothetical ACT assignment rules. If we have such a method, we could evaluate the efficacy of the various rules of thumb employed in clinics and arrive at a more data-driven approach.&lt;/p&gt;
&lt;p&gt;Luckily, using data from the Phase III AAML1031 trial, we can estimate effects of such ACT treatment strategies on survival. In the trial, patients move through a sequence of 4 chemo courses. Ahead of each course, an echo is conducted &amp;amp; used to decide ACT inclusion.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&#34;challenges&#34; class=&#34;section level1&#34;&gt;
&lt;h1&gt;Challenges&lt;/h1&gt;
&lt;p&gt;There are many impediments to valid statistical estimation. 1) ACT is not randomized in the trial but informed by time-varying features such as EF. We need to adjust for such features to get an apples-to-apples comparison of different ACT rules. 2) Some patients die or drop out before ever completing the sequence. In the latter case, we are left with incomplete survival information. 3) Treatment courses are not initiated at pre-fixed times, but depending on when subjects recover from the previous chemotherapy course.&lt;/p&gt;
&lt;p&gt;This last point suggests that the waiting times between treatments are potential confounders (e.g. slower recovery after previous treatment may inform subsequent treatment and drive survival) - quite a unique type of time-varying confounding which requires modifications to the usual g-computation algorithm for sequential treatments&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&#34;a-bayesian-semiparametric-method&#34; class=&#34;section level1&#34;&gt;
&lt;h1&gt;A Bayesian Semiparametric Method&lt;/h1&gt;
&lt;p&gt;We model the causal structure using a non-homogenous continuous-time transition process. After each course, patients can transition into a state of subsequent death or transition into a state of subsequent treatment - whichever comes first - in continuous-time. These process is characterized by a pair of transition probabilities: one pair for each treatment course. We use Bayesian semiparametric hazard models to estimate the transition probabilities at each stage as a function of features available at the start of this course.&lt;/p&gt;
&lt;p&gt;Causal effects of certain rules are computed by simulating from the transition process under a specified rule and computing the proportion of simulated subjects who survive past a certain time point (e.g. 3 years, if we want to compute 3-year survival).&lt;/p&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Collaborative Causal and Bayesian Modeling</title>
      <link>https://stablemarkets.netlify.app/project/applied/</link>
      <pubDate>Wed, 01 Sep 2021 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/project/applied/</guid>
      <description>&lt;p&gt;This is a collection of some applied work with particularly interesting Bayesian and/or causal modeling. For instance, Hubbard et al. use a Bayesian mixture model to infer patients&#39; unknown diabetes status in noisy EHR data. Harrison et al. use a Bayesian hierarchical zero-inflated model to assess difference in costs associated with a cost-lowering healthcare intervention. Takvorian et al. use a difference-in-differences strategy to assess the impact of medicare expansion under ACA on cancer treatment delivery.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Introduction to Nonparametric Bayes</title>
      <link>https://stablemarkets.netlify.app/talk/introduction-to-nonparametric-bayes/</link>
      <pubDate>Wed, 18 Nov 2020 15:12:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/introduction-to-nonparametric-bayes/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Invited Discussion on Bayesian Causal Forests</title>
      <link>https://stablemarkets.netlify.app/talk/invited-discussion-on-bayesian-causal-forests/</link>
      <pubDate>Sat, 26 Sep 2020 15:05:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/invited-discussion-on-bayesian-causal-forests/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Causal Inference with Stan</title>
      <link>https://stablemarkets.netlify.app/talk/bayesian-causal-inference-with-stan/</link>
      <pubDate>Thu, 13 Aug 2020 15:05:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/bayesian-causal-inference-with-stan/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Non-parametric Bayes</title>
      <link>https://stablemarkets.netlify.app/project/bnp/</link>
      <pubDate>Fri, 10 Jul 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/project/bnp/</guid>
      <description>&lt;p&gt;Bayesian nonparametrics is a powerful class of methods including Gaussian processes, Bayesian Additive Regression Trees (BART), Gamma Processes, Dirichlet Process, etc. The central idea is to abstract away from parameters. For instance, standard methods may assume a regression function is linear, indexed by finitely many slope/intercept parameters. A prior on these finitely many parameters then induces a prior on the regression function. To avoid specifying such restrictive functional form, we need to cut out the middle-man (the parameters) and specify priors over the function &lt;em&gt;directly&lt;/em&gt;. Bayesian nonparametrics is characterized by priors over such abstract objects: priors over regressions, priors over baseline hazard functions, prior distributions over distributions themselves.&lt;/p&gt;
&lt;p&gt;These methods give you the flexibility of machine learning, with the added benefit uncertainty quantitification via full posterior inference.&lt;/p&gt;
&lt;p&gt;See below for work related to nonparametric Bayesian inference.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Bayesian Causal Inference</title>
      <link>https://stablemarkets.netlify.app/project/causalbayes/</link>
      <pubDate>Fri, 05 Jun 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/project/causalbayes/</guid>
      <description>&lt;p&gt;Causal inference is broadly concerned with estimating parameters governing the causal mechanisms between an intervention or treatment of interest and an outcome. Causal inference provides a framework for 1) constructing different estimands that have explicitly causal, rather than associational, interpretations 2) formulating the assumptions under which we can estimate these using observed data, 3) devising sensitivity analyses around violations of these assumptions, and 4) making valid inferences about these estimans. These are just some of the many advances made in the causal literature.&lt;/p&gt;
&lt;p&gt;In practice, causal inference requires complex, high-dimensional models. Here, the Bayesian paradigm has a lot to offer. For instance,&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Shrinking&lt;/strong&gt; heterogeneous (stratum-specific) causal effects towards an overall average causal effect for sparse strata.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Sparsity priors&lt;/strong&gt; such as Horseshoes and Spike-and-Slab that can regularize high-dimensional nuissance parameters. Such parameters are common in g-computation.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Sensitivity Analyses&lt;/strong&gt; around causal identification assumptions. Uncertainty about the direction and magnitude of the bias can be expressed via a prior and baked into posterior inference.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;See below for work related to Bayesian causal modeling.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Sample versus Population ATE in Bayesian Caual Estimation</title>
      <link>https://stablemarkets.netlify.app/post/post5/sate-v-pate/</link>
      <pubDate>Sun, 22 Mar 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/post/post5/sate-v-pate/</guid>
      <description>
&lt;script src=&#34;https://stablemarkets.netlify.app/rmarkdown-libs/header-attrs/header-attrs.js&#34;&gt;&lt;/script&gt;


&lt;p&gt;Writing up a quick post to clarify a point of common confusion when doing posterior inference for causal effects. All causal inference (regardless of statistical modeling paradigm in consideration) begins with expressing the target estimand in terms of unobservables (e.g. potential outcomes) and linking them to observed data with ``identification assumptions.’’ Two common estimands (which are often confused) are the population level average treatment effect (ATE) and the sample level ATE. These are two very different estimands and inferential procedures therefore differ for each. Yet, they seem to be confused with each other quite often. This post clarifies the distinction.&lt;/p&gt;
&lt;p&gt;Suppose we have a binary treatment &lt;span class=&#34;math inline&#34;&gt;\(A_i\in\{0,1\}\)&lt;/span&gt;, outcome &lt;span class=&#34;math inline&#34;&gt;\(Y_i\)&lt;/span&gt;, and a set of pre-treatment confounders &lt;span class=&#34;math inline&#34;&gt;\(L_i\)&lt;/span&gt; for &lt;span class=&#34;math inline&#34;&gt;\(n\)&lt;/span&gt; independent subjects. Let the observed data be &lt;span class=&#34;math inline&#34;&gt;\(D = \{Y_i, A_i, L_i \}_{i=1}^n\)&lt;/span&gt;. Much of the following can be found in &lt;a href=&#34;https://onlinelibrary.wiley.com/doi/full/10.1002/sim.8761&#34;&gt;Oganisian &amp;amp; Roy, 2020&lt;/a&gt; and &lt;a href=&#34;https://projecteuclid.org/journals/statistical-science/volume-33/issue-2/Causal-Inference-A-Missing-Data-Perspective/10.1214/18-STS645.full&#34;&gt;Ding and Li, 2018&lt;/a&gt;.&lt;/p&gt;
&lt;div id=&#34;the-population-level-ate&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;The population-level ATE&lt;/h2&gt;
&lt;p&gt;The population-level in potential outcome notation can be expressed as
&lt;span class=&#34;math display&#34;&gt;\[ \Psi = E[Y^1 - Y^0] \]&lt;/span&gt;
Under certain identification assumptions, this is identified via the g-formula:
&lt;span class=&#34;math display&#34;&gt;\[ \Psi(\mu, P_L) = \int_{\mathcal{L}} \Big( \mu(1, l)- \mu(0, l)\Big) dP_L(l) \]&lt;/span&gt;
Where &lt;span class=&#34;math inline&#34;&gt;\(\mu(a, l) = E[Y\mid A=a, L=l]\)&lt;/span&gt; is the outcome regression function. Here the notation &lt;span class=&#34;math inline&#34;&gt;\(\Psi(\mu, P_L)\)&lt;/span&gt; makes it explicit that the causal estimand is a function of two unknowns: the unknown regression function and the unknown confounder distribution. If we have estimates of these objects, &lt;span class=&#34;math inline&#34;&gt;\(\hat \mu\)&lt;/span&gt; and &lt;span class=&#34;math inline&#34;&gt;\(\hat P_L\)&lt;/span&gt;, frequentist inference can be done via a plug-in estimator
&lt;span class=&#34;math display&#34;&gt;\[ \hat\Psi(\hat \mu, \hat P_L) = \int_{\mathcal{L}} \Big( \hat\mu(1, l)- \hat\mu(0, l)\Big) d\hat P_L(l) \]&lt;/span&gt;
For example, if we could fit a standard GLM with some inverse-link function,&lt;span class=&#34;math inline&#34;&gt;\(g^{-1}\)&lt;/span&gt;, &lt;span class=&#34;math inline&#34;&gt;\(\hat\mu(a, l) = g^{-1}(\hat \beta_0 + \hat \beta_1 A + \hat L&amp;#39;\beta_2)\)&lt;/span&gt;. Typically we use the empirical distribution for the confounder distribution estimate, &lt;span class=&#34;math inline&#34;&gt;\(\hat P_L(l) = \sum_{i=1}^n \frac{1}{n} I(L_i = l)\)&lt;/span&gt;. So we have
&lt;span class=&#34;math display&#34;&gt;\[
\begin{align*}
\hat\Psi(\hat \mu, \hat P_L) &amp;amp; = \int_{\mathcal{L}} \Big( \hat\mu(1, l)- \hat\mu(0, l)\Big) d\hat P_L(l) \\
                              &amp;amp; = \sum_{i=1}^n \frac{1}{n} \Big( \hat\mu(1, L_i)- \hat\mu(0, L_i)\Big) \\
\end{align*}
\]&lt;/span&gt;
That is, we end up average the difference in the mean function,&lt;span class=&#34;math inline&#34;&gt;\(\hat\mu(a, l)\)&lt;/span&gt;, under both treatments over the empirical distribution of confounders. Typically bootstrap is used to compute interval estimates for the population ATE.&lt;/p&gt;
&lt;p&gt;Bayesian inference for this quantity is also straightforward: obtain the &lt;span class=&#34;math inline&#34;&gt;\(m^{th}\)&lt;/span&gt; posterior draw of the regression function &lt;span class=&#34;math inline&#34;&gt;\(\mu^{(m)}(a,l)\)&lt;/span&gt; under your favorite Bayesian model (a Generalized Linear Model, Gaussian process, Dirichlet Process, BART, etc). Then obtain the &lt;span class=&#34;math inline&#34;&gt;\(m^{th}\)&lt;/span&gt; posterior draw of the confounder distribution. It is common to use the ``Bayesian Bootstrap’’ for this - a Bayesian analogue of the empirical distribution: &lt;span class=&#34;math inline&#34;&gt;\(P_L^{(m)}(l) = \sum_{i=1}^n \gamma_i^{(m)} I(L_i = l)\)&lt;/span&gt;, where &lt;span class=&#34;math inline&#34;&gt;\((\gamma_1^{(m)}, \gamma_2^{(m)}, \dots, \gamma_n^{(m)}) \sim Dir(1_n)\)&lt;/span&gt; are drawn froma Dirichlet Distribution. Then the posterior draw of the population-level ATE is
&lt;span class=&#34;math display&#34;&gt;\[
\begin{align*}
\Psi(\mu^{(m)}, P_L^{(m)}) &amp;amp; = \int_{\mathcal{L}} \Big(\mu^{(m)}(1, l)-\mu^{(m)}(0, l)\Big) d P_L^{(m)}(l) \\
                           &amp;amp; = \sum_{i=1}^n \gamma_i\Big(\mu^{(m)}(1, L_i)-\mu^{(m)}(0, L_i)\Big) \\
\end{align*}
\]&lt;/span&gt;
Again, we are taking a weighted average of the difference in the mean function draw, &lt;span class=&#34;math inline&#34;&gt;\(\mu^{(m)}(a, l)\)&lt;/span&gt;, under each intervention. Under the Bayesian bootstrap, the posterior expectation of each &lt;span class=&#34;math inline&#34;&gt;\(\gamma_i\)&lt;/span&gt; is 1/n - so you think can think of this as being centered around the empirical distribution. Doing this for &lt;span class=&#34;math inline&#34;&gt;\(m=1,2,\dots, M\)&lt;/span&gt; we get a set of posterior draws for the population ATE which can be used for point and interval estimation.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&#34;the-sample-level-ate&#34; class=&#34;section level2&#34;&gt;
&lt;h2&gt;The sample-level ATE&lt;/h2&gt;
&lt;p&gt;Letting &lt;span class=&#34;math inline&#34;&gt;\(\textbf{Y}^m = \{ Y_i^{1-A_i} \}_{i=1}^n\)&lt;/span&gt; be the set of missing counterfactuals for the patients in the sample. The sample-level ATE is given by
&lt;span class=&#34;math display&#34;&gt;\[ \psi(\textbf{Y}^m) = \frac{1}{n} \sum_{i=1}^n (Y_i^1 - Y_i^0) \]&lt;/span&gt;
This is a very different quantity from the population-level estimand
&lt;span class=&#34;math display&#34;&gt;\[ \Psi(\mu, P_L) = \int_{\mathcal{L}} \Big( \mu(1, l)- \mu(0, l)\Big) dP_L(l) \]&lt;/span&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;The uncertainty in the population-level ATE, &lt;span class=&#34;math inline&#34;&gt;\(\Psi(\mu, P_L)\)&lt;/span&gt;, is due to uncertainty about the unknown regression function, &lt;span class=&#34;math inline&#34;&gt;\(\mu\)&lt;/span&gt;, and confounder distribution, &lt;span class=&#34;math inline&#34;&gt;\(P_L\)&lt;/span&gt;.&lt;/li&gt;
&lt;li&gt;The uncertainty in the sample-level estimand is due to uncertainty about the missing counterfactuals, &lt;span class=&#34;math inline&#34;&gt;\(\textbf{Y}^m\)&lt;/span&gt;. After all, under SUTVA, we only observe &lt;span class=&#34;math inline&#34;&gt;\(Y_i^{A_i}\)&lt;/span&gt; while &lt;span class=&#34;math inline&#34;&gt;\(Y_i^{1-A_i}\)&lt;/span&gt; is unobserved for subject with assignment &lt;span class=&#34;math inline&#34;&gt;\(A_i\)&lt;/span&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The Bayesian solutions differ accordingly:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;To do posterior inference for the population-level ATE, we must draw the unknonwn regression function and confounder distributions from the posterior, &lt;span class=&#34;math inline&#34;&gt;\(f(\mu, P_L \mid D)\)&lt;/span&gt;&lt;/li&gt;
&lt;li&gt;To do posterior inference for the sample-level ATE, we must draw the unknown counterfactuals &lt;span class=&#34;math inline&#34;&gt;\(Y_i^{1-A_i}\)&lt;/span&gt; from the posterior &lt;span class=&#34;math inline&#34;&gt;\(f( \{ Y_i^{1-A_i} \}_{i=1}^n \mid D)\)&lt;/span&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;That last bullet is Bayesian inference for causal effects as originally described by Donald Rubin. While &lt;span class=&#34;math inline&#34;&gt;\(\Psi\)&lt;/span&gt; is identifiable, &lt;span class=&#34;math inline&#34;&gt;\(\psi\)&lt;/span&gt; is not identifiable except up to a sensitivity parameter. To show this, apply Bayes’ rule:
&lt;span class=&#34;math display&#34;&gt;\[ f( \{ Y_i^{1-A_i} \}_{i=1}^n \mid D) \propto f_A(A_i \mid L_i, Y_i^{A_i}, Y_i^{1-A_i} ) f_*(Y^A_i, Y_i^{1-A_i}\mid A_i, L_i) f_L(L_i) \]&lt;/span&gt;
if the usual ignorability holds (due to say a randomized treatment) - i.e. &lt;span class=&#34;math inline&#34;&gt;\(Y^1, Y^0 \perp A \mid L\)&lt;/span&gt; - the selection mechanism no longer depends on potential outcomes: &lt;span class=&#34;math display&#34;&gt;\[f_A(A_i \mid L_i, Y_i^{A_i}, Y_i^{1-A_i} ) = f_A(A_i \mid L_i )\]&lt;/span&gt;
and, along with &lt;span class=&#34;math inline&#34;&gt;\(f_L\)&lt;/span&gt; can be dropped while maintaining proportionality. But the crucial thing here is that the remaining joint distribution &lt;span class=&#34;math inline&#34;&gt;\(f_*(Y^A_i, Y_i^{1-A_i}\mid A_i, L_i)\)&lt;/span&gt; is  - we never observe both potential outcomes for subject &lt;span class=&#34;math inline&#34;&gt;\(i\)&lt;/span&gt;. This complicates sample-level inference. We could still make inferences. For instance, by invoking de Finetti, we could model it as &lt;span class=&#34;math inline&#34;&gt;\(N_2(Y_i^{A_i}, Y_i^{1-A_i}\mid A_i, L_i; \eta, \Sigma ) p(\eta)p(\Sigma)\)&lt;/span&gt;. Where &lt;span class=&#34;math inline&#34;&gt;\(N_2\)&lt;/span&gt; indicates a bivariate normal distribution with mean vector &lt;span class=&#34;math inline&#34;&gt;\(\eta\)&lt;/span&gt; and 2x2 covariance matrix, &lt;span class=&#34;math inline&#34;&gt;\(\Sigma\)&lt;/span&gt;. But the off-diagonal terms of &lt;span class=&#34;math inline&#34;&gt;\(\Sigma\)&lt;/span&gt;, $ Cov( Y_i^{A_i}, Y_i^{1-A_i} ) $, cannot be learned from data. Thus we call it a sensitivity parameter. The posterior is still defined, but will be completely driven by the prior &lt;span class=&#34;math inline&#34;&gt;\(p(\Sigma)\)&lt;/span&gt;. Thus, the sample-level effect is significantly more complicated .&lt;/p&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Association of ACA Expansion with Timely Cancer Treatment</title>
      <link>https://stablemarkets.netlify.app/publication/acadid/</link>
      <pubDate>Wed, 19 Feb 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/acadid/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Practical Introduction to Bayesian Estimation of Causal Effects: Parametric and Nonparametric Approaches</title>
      <link>https://stablemarkets.netlify.app/publication/bayescausal/</link>
      <pubDate>Tue, 11 Feb 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/bayescausal/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Nonparametric Cost-Effectiveness Analyses: Causal Estimation and Adaptive Subgroup Discovery</title>
      <link>https://stablemarkets.netlify.app/publication/bnpce/</link>
      <pubDate>Tue, 11 Feb 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/bnpce/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients</title>
      <link>https://stablemarkets.netlify.app/publication/ajmc/</link>
      <pubDate>Tue, 11 Feb 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/ajmc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Bayesian Nonparametric Method for Zero-Inflated Outcomes: Prediction, Clustering, and Causal Inference</title>
      <link>https://stablemarkets.netlify.app/publication/zdp/</link>
      <pubDate>Sat, 01 Feb 2020 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/zdp/</guid>
      <description></description>
    </item>
    
    <item>
      <title>BNP Model for Zero-Inflated Outcomes: Clustering, Prediction, Causal Inference</title>
      <link>https://stablemarkets.netlify.app/talk/bnp-model-for-zero-inflated-outcomes-clustering-prediction-causal-inference/</link>
      <pubDate>Wed, 31 Jul 2019 15:05:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/talk/bnp-model-for-zero-inflated-outcomes-clustering-prediction-causal-inference/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Specifying Accelerated Failure Time Models in STAN</title>
      <link>https://stablemarkets.netlify.app/post/post2/specifying-accelerated-failure-time-models-in-stan/</link>
      <pubDate>Sat, 09 Mar 2019 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/post/post2/specifying-accelerated-failure-time-models-in-stan/</guid>
      <description>
&lt;script src=&#34;https://stablemarkets.netlify.app/rmarkdown-libs/header-attrs/header-attrs.js&#34;&gt;&lt;/script&gt;


&lt;p&gt;This post is an add-on to my &lt;a href=&#34;https://stablemarkets.netlify.com/post/post1/bayesian-survival-analysis-with-data-augmentation/&#34;&gt;previous post&lt;/a&gt; about augmented gibbs sampling for censored survival times. If you’re not a complete maniac like me, then you probably don’t want to code your own sampler from scratch like I did in that previous post. Luckily you don’t have to because you can easily specify that same model in &lt;a href=&#34;https://mc-stan.org/users/interfaces/rstan&#34;&gt;Stan&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Let’s start with simulating some randomly censored data from a Weibull model. In this case, we just include a binary indicator and are interested in characterizing survival between these two groups.&lt;/p&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;set.seed(1)

n &amp;lt;- 1000

# simulate covariates (just a binary treatment indicator)
A &amp;lt;- rbinom(n, 1, .5)
X &amp;lt;- model.matrix(~ A)

# true parameters
true_beta &amp;lt;- (1/2)*matrix(c(-1/3, 2), ncol=1)
true_mu &amp;lt;- X %*% true_beta

true_sigma &amp;lt;- 1

true_alpha &amp;lt;- 1/true_sigma
true_lambda &amp;lt;- exp(-1*true_mu*true_alpha)

# simulate censoring and survival times
survt = rweibull(n, shape=true_alpha, scale = true_lambda) 
cent = rweibull(n, shape=true_alpha, scale = true_lambda)

## observed data:
#censoring indicator
delta &amp;lt;- cent &amp;lt; survt
survt[delta==1] &amp;lt;- cent[delta==1] # censor survival time.

# count number of missing/censored survival times
n_miss &amp;lt;- sum(delta)

d_list &amp;lt;- list(N_m = n_miss, N_o = n - n_miss, P=2, # number of betas
               # data for censored subjects
               y_m=survt[delta==1], X_m=X[delta==1,],
               # data for uncensored subjects
               y_o=survt[delta==0], X_o=X[delta==0,])&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;The list &lt;code&gt;d_list&lt;/code&gt; is what we’ll eventually feed to Stan. Below is the Stan model for Weibull distributed survival times. Note in the transformed parameters block we specify the canonical accelerated failure time (AFT) parameterization - modeling the scale as a function of the shape parameter, &lt;span class=&#34;math inline&#34;&gt;\(\alpha\)&lt;/span&gt;, and covariates.&lt;/p&gt;
&lt;p&gt;In the model block, we specify the likelihood as the Weibull density for uncensored subjects, and then augment the likelihood with evaluations from the Weibull survival function (&lt;code&gt;_lccdf&lt;/code&gt;).&lt;/p&gt;
&lt;p&gt;The generated quantities block transforms the parameters to get posterior draws of the hazard ratio (as specified in my &lt;a href=&#34;https://stablemarkets.netlify.com/post/post1/bayesian-survival-analysis-with-data-augmentation/&#34;&gt;previous post&lt;/a&gt; ) as well as posterior draws of the survival function.&lt;/p&gt;
&lt;pre class=&#34;stan&#34;&gt;&lt;code&gt;data {
  int&amp;lt;lower=0&amp;gt; P; // number of beta parameters
  
  // data for censored subjects
  int&amp;lt;lower=0&amp;gt; N_m;
  matrix[N_m,P] X_m;
  vector[N_m] y_m;
  
  // data for observed subjects
  int&amp;lt;lower=0&amp;gt; N_o;
  matrix[N_o,P] X_o;
  real y_o[N_o];
}

parameters {
  vector[P] beta;                
  real&amp;lt;lower=0&amp;gt; alpha; // Weibull Shape      
}

transformed parameters{
  // model Weibull rate as function of covariates
  vector[N_m] lambda_m;
  vector[N_o] lambda_o;
  
  // standard weibull AFT re-parameterization
  lambda_m = exp((X_m*beta)*alpha);
  lambda_o = exp((X_o*beta)*alpha);
}

model {
  beta ~ normal(0, 100);
  alpha ~ exponential(1);
  
  // evaluate likelihood for censored and uncensored subjects
  target += weibull_lpdf(y_o | alpha, lambda_o);
  target += weibull_lccdf(y_m | alpha, lambda_m);
}


// generate posterior quantities of interest
generated quantities{
  vector[1000] post_pred_trt;
  vector[1000] post_pred_pbo;
  real lambda_trt; 
  real lambda_pbo; 
  real hazard_ratio;
  
  // generate hazard ratio
  lambda_trt = exp((beta[1] + beta[2])*alpha ) ;
  lambda_pbo = exp((beta[1])*alpha ) ;
  
  hazard_ratio = exp(beta[2]*alpha ) ;
  
  // generate survival times (for plotting survival curves)
  for(i in 1:1000){
    post_pred_trt[i] = weibull_rng(alpha,  lambda_trt);
    post_pred_pbo[i] = weibull_rng(alpha,  lambda_pbo);
  }
}
&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;The Stan model specified above is stored in an object called &lt;code&gt;weibull_mod&lt;/code&gt;, which is called below in &lt;code&gt;sampling()&lt;/code&gt;. The code below samples from the posterior and outputs posterior draws of the hazard and predicted survival times.&lt;/p&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;weibull_fit &amp;lt;- sampling(weibull_mod,
                data = d_list, 
                chains = 1, iter=20000, warmup=19000, save_warmup=F,
                pars= c(&amp;#39;hazard_ratio&amp;#39;,&amp;#39;post_pred_trt&amp;#39;,&amp;#39;post_pred_pbo&amp;#39;))&lt;/code&gt;&lt;/pre&gt;
&lt;pre&gt;&lt;code&gt;## 
## SAMPLING FOR MODEL &amp;#39;80acc0f9293b946800a710dd7f5e211c&amp;#39; NOW (CHAIN 1).
## Chain 1: 
## Chain 1: Gradient evaluation took 0.000172 seconds
## Chain 1: 1000 transitions using 10 leapfrog steps per transition would take 1.72 seconds.
## Chain 1: Adjust your expectations accordingly!
## Chain 1: 
## Chain 1: 
## Chain 1: Iteration:     1 / 20000 [  0%]  (Warmup)
## Chain 1: Iteration:  2000 / 20000 [ 10%]  (Warmup)
## Chain 1: Iteration:  4000 / 20000 [ 20%]  (Warmup)
## Chain 1: Iteration:  6000 / 20000 [ 30%]  (Warmup)
## Chain 1: Iteration:  8000 / 20000 [ 40%]  (Warmup)
## Chain 1: Iteration: 10000 / 20000 [ 50%]  (Warmup)
## Chain 1: Iteration: 12000 / 20000 [ 60%]  (Warmup)
## Chain 1: Iteration: 14000 / 20000 [ 70%]  (Warmup)
## Chain 1: Iteration: 16000 / 20000 [ 80%]  (Warmup)
## Chain 1: Iteration: 18000 / 20000 [ 90%]  (Warmup)
## Chain 1: Iteration: 19001 / 20000 [ 95%]  (Sampling)
## Chain 1: Iteration: 20000 / 20000 [100%]  (Sampling)
## Chain 1: 
## Chain 1:  Elapsed Time: 12.2212 seconds (Warm-up)
## Chain 1:                1.03363 seconds (Sampling)
## Chain 1:                13.2548 seconds (Total)
## Chain 1:&lt;/code&gt;&lt;/pre&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;post_draws&amp;lt;-extract(weibull_fit)&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;Below we plot posterior distribution of the hazard ratio. The red line indicates the true value under which we generated the data.&lt;/p&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;hist(post_draws$hazard_ratio,
     xlab=&amp;#39;Hazard Ratio&amp;#39;, main=&amp;#39;Hazard Ratio Posterior Distribution&amp;#39;)
abline(v=exp(-1*true_beta[2,1]*true_alpha), col=&amp;#39;red&amp;#39;)&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;&lt;img src=&#34;https://stablemarkets.netlify.app/post/post2/2019-03-09-specifying-accelerated-failure-time-models-in-stan_files/figure-html/plot_hazard_ratio-1.png&#34; width=&#34;672&#34; /&gt;&lt;/p&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;mean(post_draws$hazard_ratio)&lt;/code&gt;&lt;/pre&gt;
&lt;pre&gt;&lt;code&gt;## [1] 0.3658342&lt;/code&gt;&lt;/pre&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;quantile(post_draws$hazard_ratio, probs = c(.025, .975))&lt;/code&gt;&lt;/pre&gt;
&lt;pre&gt;&lt;code&gt;##      2.5%     97.5% 
## 0.3039049 0.4376196&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;Below we plot the survival functions. Note these results are very similar to the augmented sampler coded in the previous post.&lt;/p&gt;
&lt;pre class=&#34;r&#34;&gt;&lt;code&gt;plot(survfit(Surv(survt, 1-delta) ~ A ), col=c(&amp;#39;black&amp;#39;,&amp;#39;blue&amp;#39;),
     xlab=&amp;#39;Time&amp;#39;,ylab=&amp;#39;Survival Probability&amp;#39;, conf.int=T)

for(i in 1:1000){
  trt_ecdf &amp;lt;- ecdf(post_draws$post_pred_trt[i,])
  curve(1 - trt_ecdf(x), from = 0, to=4, add=T, col=&amp;#39;gray&amp;#39;)
  
  pbo_ecdf &amp;lt;- ecdf(post_draws$post_pred_pbo[i,])
  curve(1 - pbo_ecdf(x), from = 0, to=4, add=T, col=&amp;#39;lightblue&amp;#39;)
}

lines(survfit(Surv(survt, 1-delta) ~ A ), col=c(&amp;#39;black&amp;#39;,&amp;#39;blue&amp;#39;), add=T,
      conf.int=T)

legend(&amp;#39;topright&amp;#39;, 
       legend = c(&amp;#39;KM Curve and Intervals (TRT)&amp;#39;,
                  &amp;#39;Posterior Survival Draws (TRT)&amp;#39;,
                  &amp;#39;KM Curve and Intervals (PBO)&amp;#39;,
                  &amp;#39;Posterior Survival Draws (PBO)&amp;#39;),
       col=c(&amp;#39;black&amp;#39;,&amp;#39;gray&amp;#39;,&amp;#39;blue&amp;#39;,&amp;#39;lightblue&amp;#39;), 
       lty=c(1,0,1,0), pch=c(NA,15,NA,15), bty=&amp;#39;n&amp;#39;)&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;&lt;img src=&#34;https://stablemarkets.netlify.app/post/post2/2019-03-09-specifying-accelerated-failure-time-models-in-stan_files/figure-html/plot_survival-1.png&#34; width=&#34;672&#34; /&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Slides</title>
      <link>https://stablemarkets.netlify.app/slides/example/</link>
      <pubDate>Tue, 05 Feb 2019 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/slides/example/</guid>
      <description>&lt;h1 id=&#34;create-slides-in-markdown-with-wowchemy&#34;&gt;Create slides in Markdown with Wowchemy&lt;/h1&gt;
&lt;p&gt;&lt;a href=&#34;https://wowchemy.com/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Wowchemy&lt;/a&gt; | &lt;a href=&#34;https://owchemy.com/docs/managing-content/#create-slides&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Documentation&lt;/a&gt;&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;features&#34;&gt;Features&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Efficiently write slides in Markdown&lt;/li&gt;
&lt;li&gt;3-in-1: Create, Present, and Publish your slides&lt;/li&gt;
&lt;li&gt;Supports speaker notes&lt;/li&gt;
&lt;li&gt;Mobile friendly slides&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;controls&#34;&gt;Controls&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Next: &lt;code&gt;Right Arrow&lt;/code&gt; or &lt;code&gt;Space&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Previous: &lt;code&gt;Left Arrow&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Start: &lt;code&gt;Home&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Finish: &lt;code&gt;End&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Overview: &lt;code&gt;Esc&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Speaker notes: &lt;code&gt;S&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Fullscreen: &lt;code&gt;F&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;Zoom: &lt;code&gt;Alt + Click&lt;/code&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/hakimel/reveal.js#pdf-export&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;PDF Export&lt;/a&gt;: &lt;code&gt;E&lt;/code&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;code-highlighting&#34;&gt;Code Highlighting&lt;/h2&gt;
&lt;p&gt;Inline code: &lt;code&gt;variable&lt;/code&gt;&lt;/p&gt;
&lt;p&gt;Code block:&lt;/p&gt;
&lt;pre&gt;&lt;code class=&#34;language-python&#34;&gt;porridge = &amp;quot;blueberry&amp;quot;
if porridge == &amp;quot;blueberry&amp;quot;:
    print(&amp;quot;Eating...&amp;quot;)
&lt;/code&gt;&lt;/pre&gt;
&lt;hr&gt;
&lt;h2 id=&#34;math&#34;&gt;Math&lt;/h2&gt;
&lt;p&gt;In-line math: $x + y = z$&lt;/p&gt;
&lt;p&gt;Block math:&lt;/p&gt;
&lt;p&gt;$$
f\left( x \right) = ;\frac{{2\left( {x + 4} \right)\left( {x - 4} \right)}}{{\left( {x + 4} \right)\left( {x + 1} \right)}}
$$&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;fragments&#34;&gt;Fragments&lt;/h2&gt;
&lt;p&gt;Make content appear incrementally&lt;/p&gt;
&lt;pre&gt;&lt;code&gt;{{% fragment %}} One {{% /fragment %}}
{{% fragment %}} **Two** {{% /fragment %}}
{{% fragment %}} Three {{% /fragment %}}
&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;Press &lt;code&gt;Space&lt;/code&gt; to play!&lt;/p&gt;
&lt;p&gt;&lt;span class=&#34;fragment &#34; &gt;
One
&lt;/span&gt;
&lt;span class=&#34;fragment &#34; &gt;
&lt;strong&gt;Two&lt;/strong&gt;
&lt;/span&gt;
&lt;span class=&#34;fragment &#34; &gt;
Three
&lt;/span&gt;&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;A fragment can accept two optional parameters:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;code&gt;class&lt;/code&gt;: use a custom style (requires definition in custom CSS)&lt;/li&gt;
&lt;li&gt;&lt;code&gt;weight&lt;/code&gt;: sets the order in which a fragment appears&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;speaker-notes&#34;&gt;Speaker Notes&lt;/h2&gt;
&lt;p&gt;Add speaker notes to your presentation&lt;/p&gt;
&lt;pre&gt;&lt;code class=&#34;language-markdown&#34;&gt;{{% speaker_note %}}
- Only the speaker can read these notes
- Press `S` key to view
{{% /speaker_note %}}
&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;Press the &lt;code&gt;S&lt;/code&gt; key to view the speaker notes!&lt;/p&gt;
&lt;aside class=&#34;notes&#34;&gt;
  &lt;ul&gt;
&lt;li&gt;Only the speaker can read these notes&lt;/li&gt;
&lt;li&gt;Press &lt;code&gt;S&lt;/code&gt; key to view&lt;/li&gt;
&lt;/ul&gt;

&lt;/aside&gt;
&lt;hr&gt;
&lt;h2 id=&#34;themes&#34;&gt;Themes&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;black: Black background, white text, blue links (default)&lt;/li&gt;
&lt;li&gt;white: White background, black text, blue links&lt;/li&gt;
&lt;li&gt;league: Gray background, white text, blue links&lt;/li&gt;
&lt;li&gt;beige: Beige background, dark text, brown links&lt;/li&gt;
&lt;li&gt;sky: Blue background, thin dark text, blue links&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;ul&gt;
&lt;li&gt;night: Black background, thick white text, orange links&lt;/li&gt;
&lt;li&gt;serif: Cappuccino background, gray text, brown links&lt;/li&gt;
&lt;li&gt;simple: White background, black text, blue links&lt;/li&gt;
&lt;li&gt;solarized: Cream-colored background, dark green text, blue links&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;

&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;/media/boards.jpg&#34;
  &gt;

&lt;h2 id=&#34;custom-slide&#34;&gt;Custom Slide&lt;/h2&gt;
&lt;p&gt;Customize the slide style and background&lt;/p&gt;
&lt;pre&gt;&lt;code class=&#34;language-markdown&#34;&gt;{{&amp;lt; slide background-image=&amp;quot;/media/boards.jpg&amp;quot; &amp;gt;}}
{{&amp;lt; slide background-color=&amp;quot;#0000FF&amp;quot; &amp;gt;}}
{{&amp;lt; slide class=&amp;quot;my-style&amp;quot; &amp;gt;}}
&lt;/code&gt;&lt;/pre&gt;
&lt;hr&gt;
&lt;h2 id=&#34;custom-css-example&#34;&gt;Custom CSS Example&lt;/h2&gt;
&lt;p&gt;Let&amp;rsquo;s make headers navy colored.&lt;/p&gt;
&lt;p&gt;Create &lt;code&gt;assets/css/reveal_custom.css&lt;/code&gt; with:&lt;/p&gt;
&lt;pre&gt;&lt;code class=&#34;language-css&#34;&gt;.reveal section h1,
.reveal section h2,
.reveal section h3 {
  color: navy;
}
&lt;/code&gt;&lt;/pre&gt;
&lt;hr&gt;
&lt;h1 id=&#34;questions&#34;&gt;Questions?&lt;/h1&gt;
&lt;p&gt;&lt;a href=&#34;https://github.com/wowchemy/wowchemy-hugo-modules/discussions&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Ask&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;a href=&#34;https://wowchemy.com/docs/managing-content/#create-slides&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Documentation&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>A Bayesian latent class approach for EHR‐based phenotyping</title>
      <link>https://stablemarkets.netlify.app/publication/bayes_latent_phenotype/</link>
      <pubDate>Mon, 03 Sep 2018 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/publication/bayes_latent_phenotype/</guid>
      <description></description>
    </item>
    
    <item>
      <title>ChiRP</title>
      <link>https://stablemarkets.netlify.app/project/chirp/</link>
      <pubDate>Wed, 27 Apr 2016 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/project/chirp/</guid>
      <description></description>
    </item>
    
    <item>
      <title></title>
      <link>https://stablemarkets.netlify.app/admin/config.yml</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://stablemarkets.netlify.app/admin/config.yml</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
